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Abstract
Cranial placodes are ectodermal regions that contribute extensively to the vertebrate peripheral sensory nervous system. The development of
the ophthalmic trigeminal (opV) placode, which gives rise only to sensory neurons of the ophthalmic lobe of the trigeminal ganglion, is a useful
model of sensory neuron development. While key differentiation processes have been characterized at the tissue and cellular levels, the signaling
pathways governing opV placode development have not. Here we tested in chick whether the canonical Wnt signaling pathway regulates opV
placode development. By introducing a Wnt reporter into embryonic chick head ectoderm, we show that the canonical pathway is active in Pax3+
opV placode cells as, or shortly after, they are induced to express Pax3. Blocking the canonical Wnt pathway resulted in the failure of targeted
cells to adopt or maintain an opV fate, as assayed by the expression of various markers including Pax3, FGFR4, Eya2, and the neuronal
differentiation markers Islet1, neurofilament, and NeuN, although, surprisingly, it led to upregulation of Neurogenin2, both in the opV placode
and elsewhere in the ectoderm. Activating the canonical Wnt signaling pathway, however, was not sufficient to induce Pax3, the earliest specific
marker of the opV placode. We conclude that canonical Wnt signaling is necessary for normal opV placode development, and propose that other
molecular cues are required in addition to Wnt signaling to promote cells toward an opV placode fate.
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In vertebrates, neurogenic placodes, along with a subpopula-
tion of neural crest cells, contribute sensory neurons to the
developing cranial ganglia. While some neurogenic placodes,
such as the otic and olfactory placodes, give rise to several non-
neuronal and neuronal derivatives, the trigeminal and epibran-
chial (geniculate, petrosal, and nodose) placodes give rise
exclusively to sensory neurons (reviewed in Baker and Bronner-
Fraser, 2001; Schlosser, 2006). The development of these solely
neurogenic placodes provides an advantageous model for
understanding the stepwise process of neurogenesis. In the⁎ Corresponding author. Department of Physiology and Developmental
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doi:10.1016/j.ydbio.2007.05.032case of the trigeminal ganglion (the sensory ganglion of cranial
nerve V), sensory neurons derive from neural crest cells and two
placodes, the ophthalmic trigeminal (opV) and maxillomandib-
ular trigeminal (mmV) placodes. Each placode contributes
neurons to the distal region of its respective ganglionic lobe,
while the neural crest contributes the proximal neurons as well
as glial cells (D'Amico-Martel and Noden, 1983; reviewed in
Baker and Bronner-Fraser, 2001; Schlosser, 2006). Until the last
decade, research on trigeminal placode induction was not well
advanced, primarily due to the lack of molecular markers for
placodal epithelia (Noden, 1993). Stark et al. (1997) identified
the paired-domain/homeodomain transcription factor Pax3 as
the earliest known gene expressed in the avian opV placode.
Using Pax3 as a marker, the tissue interactions involved in
induction and specification of opV placode cells were
identified. It was shown that a diffusible signal(s) from the
neural tube induces Pax3 expression in the placode (Stark et al.,
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performed to better characterize the timing and tissue interac-
tions involved in the competence, induction, and specification
of the opV placode (Baker et al., 1999). It was shown that the
Pax3-inducing signal is present throughout most of the dorsal
neural tube, and that early in development the entire head
ectoderm is competent to form Pax3+ opV placode cells (Baker
et al., 1999). Similar experiments showed that Pax3 expression
in opV placode ectoderm correlates with specification and
commitment to a Pax3+, cutaneous sensory neuron fate (Baker
et al., 1999; Baker and Bronner-Fraser, 2000; Baker et al.,
2002). While these studies revealed the cellular and tissue
interactions needed for opV placode formation, the signaling
molecules involved in this process were not determined. While
other research has shown, for example, that epibranchial
placode induction in chick and zebrafish requires BMPs and
FGFs originating from the pharyngeal endoderm and cephalic
mesoderm (Begbie et al., 1999; Holzschuh et al., 2005;
Nechiporuk et al., 2005, 2007; Nikaido et al., 2007; Sun et
al., 2007), and that FGF and Wnt signaling is required for the
initial development and maintenance of the otic placode (see
Ladher et al., 2000, 2005; Martin and Groves, 2006; Ohyama et
al., 2006), such molecules have not yet been identified for the
trigeminal placodes.
Because it was previously shown that opV placode-inducing
activity is present in the dorsal neural tube, we aimed to identify
candidate-inducing molecules expressed in this tissue. Multiple
Wnt family members, such as Wnt-1, 2, -3a, and -4, can be
detected throughout the neural tube in early chick embryos
(Hollyday et al., 1995; Marcelle et al., 1997). For example,
Wnt-1 expression begins as early as the 3-somite stage (ss) in
the dorsal neural tube. By the 10ss, expression is found
throughout the midbrain, hindbrain, and the future spinal cord.
By the 14ss, expression is restricted to a narrow region in the
dorsal midline encircling the midbrain/hindbrain boundary,
directly adjacent to the opV placode. Furthermore, the Wnt
receptors Frizzled-2 (Fz-2) and Fz-7 are expressed in a pattern
consistent with a potential role in receiving an opV placode-
inducing signal. By the 3ss, Fz-7 is strongly expressed in cranial
ectoderm, later becoming restricted to the presumptive
trigeminal placode, persisting through the 25ss. Fz-2 also
begins to be faintly expressed at the 3ss in the cranial ectoderm,
and by the 7–10ss becomes broadly expressed in cranial
ectoderm, again persisting through the 25ss (Stark et al., 2000).
Correlating evidence from other vertebrate models also suggests
that Wnt signaling is a candidate for opV placode induction. In
Wnt-1 null and Wnt-1/Wnt-3a double knockout mice, the opV
nerve is considerably reduced, whereas Wnt-3a null mice have
normal opV branching (Ikeya et al., 1997). Furthermore,
trigeminal neurons expand rostrally in zebrafish headless
mutants, in which canonical Wnt signaling is over-activated
(Kim et al., 2000). Considering both the functional data from
the mouse and zebrafish, and the Wnt/Fz expression data in the
chick, we hypothesized that Wnt signaling is involved in opV
placode cell specification and/or later development.
Wnt/Frizzled signaling has been shown to activate three
separate intracellular pathways. Activation of the canonicalcascade leads to cytoplasmic stabilization of β-catenin which
translocates to the nucleus and associates with TCF/LEF
transcription factors. The binding of this complex leads to
canonical Wnt target gene expression and can lead to
determination of cell fate and differentiation (Veeman et al.,
2003). The non-canonical Wnt pathways include the planar
cell polarity pathway, which is involved in cytoskeletal
rearrangements, and the Ca2+pathway which has been shown
to be involved in cell migration and heart development
(Huelsken and Behrens, 2002; Kuhl, 2004). Because genetic
evidence strongly suggests that Wnt-1 and Wnt-3a signal via
the β-catenin pathway, we focused our efforts on investigat-
ing canonical Wnt signaling in opV placode development.
Using in ovo electroporation to disrupt or activate the cano-
nical Wnt signaling pathway in opV placode ectoderm, we
show that blocking canonical Wnt signaling disrupts all
aspects of opV placode differentiation, including expression
of the opV placode markers Pax3, FGF receptor 4, and
Eya2, as well as delamination and neuronal differentiation.
However, canonical Wnt signaling is not sufficient to induce
Pax3 in competent ectoderm, suggesting a more complex
process requiring multiple signals for opV placodal cell fate
determination.Materials and methods
Expression reagents
A modified red fluorescent protein (RFP) Wnt reporter electroporation
construct, made by replacing the LacZ gene of the TOPGAL construct
(DasGupta and Fuchs, 1999) with nuclear RFP, was a kind gift from Dr. Andy
Groves (House Ear Institute, Los Angeles). Dominant active human β-catenin
and dominant negative human TCF4 (Tetsu and McCormick, 1999) inserted into
the pCIG vector with IRES-nuclear localized green fluorescent protein (GFP), as
well as the pCIG-GFP control vector were a kind gift from Dr. Andy McMahon
(Megason and McMahon, 2002). These expression constructs were prepared for
electroporation by resuspending at a concentration of 4–8 μg/μl in water with
Fast green added for visualization.
In ovo electroporation of chicken embryos
Fertilized chicken (Gallus gallus) eggs were obtained from local farms and
incubated to the desired stage in a humidified incubator at 38 °C. The DNA
constructs described above were electroporated into 2–14 somite stage (ss)
chicken embryos using standard electroporation techniques, where electrodes
were placed on either side of the embryo, or (most often) using a vertical
electroporation method, where the reference electrode was placed underneath
the embryo through a small hole made outside the area opaca, and the driving
electrode was placed directly above the area of interest (BTX 820 electroporator
from Genetronics: five 10 ms pulses of 10 Veach, 1 s gap between each pulse; or
TSS20 Ovodyne electroporator from Intracel Ltd., Shepreth, UK: four 50 ms
pulses of 4 V each, 1 s gap between each pulse).
Foil barrier experiments
Following electroporation in 3–6 somite stage embryos, as described above,
a slit between the ectoderm and the neural folds was made using a glass needle.
A tantalum foil barrier was then positioned in the slit using fine forceps. Barriers
were made by cutting 7.5 μm thick tantalum foil (Goodfellow #TA000280) into
pieces of approximately 250×350 μm, which were then shaped using fine
forceps (Stark et al., 1997). Embryos were collected after 24 h and prepared for
cryosectioning and immunohistochemical staining.
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Chicken Pax3 (Matsunaga et al., 2001), FGFR4 (Marcelle et al., 1995),
Eya2 (Litsiou et al., 2005; kind gift of Dr Andrea Streit), and Ngn2 (Perez
et al., 1999; kind gift of Prof. David Anderson) digoxigenin-labeled RNA
probes were synthesized as described by Henrique et al. (1995).
For whole-mount in situ hybridization (Pax3), embryos were incubated for
12–48 h after electroporation before being fixed in 4% formaldehyde and
processed for whole-mount in situ hybridization according to Henrique et al.
(1995).
For in situ hybridization on wax sections (FGFR4, Eya2, Ngn2), embryos
were fixed in modified Carnoy's solution (60% ethanol, 11.1% formaldehyde,
10% glacial acetic acid), washed in diethylpyrocarbonate (DEPC)-treated
phosphate-buffered saline (PBS), dehydrated into methanol, cleared in Histosol
(National Diagnostics), embedded in paraffin wax (Raymond Lamb) and
sectioned at 8 μm with a rotary microtome (Microm). Sections were mounted in
distilled water on Superfrost® Plus slides (VWR), and dried overnight at 37 °C.
In situ hybridization was carried out using a Boekel slide incubator according to
Etchevers et al. (2001), except that the slides were not treated with proteinase K,
the first two post-hybridization washes were in pre-warmed 50% formamide, 1×
SSC, 0.1% Tween-20, and the color reaction solution contained 5% polyvinyl
alcohol (Sigma).
Immunohistochemistry and analysis
The following primary antibodies were used: Pax3 (mouse IgG2a; Baker
et al., 1999), Pax2 (rabbit; Zymed/Invitrogen), Pax6 (mouse IgG1; Develop-
mental Studies Hybridoma Bank: DSHB), Islet-1 (mouse IgG2b; DSHB),
neurofilament (mouse IgG1 DSHB), NeuN (mouse IgG1; Chemicon) and GFP
(rabbit; Molecular Probes/Invitrogen). The Developmental Studies Hybridoma
Bank (DSHB) was developed under the auspices of the NICHD and is
maintained by the University of Iowa, Department of Biological Sciences, Iowa
City, IA 52242. Appropriately matched Alexa488-, Alexa546- or Alexa594-
conjugated goat anti-mouse or goat anti-rabbit secondary antibodies were
obtained from Molecular Probes/Invitrogen; biotinylated goat anti-mouse
secondary antibodies were obtained from Southern Biotech.
For immunohistochemistry on cryosections, embryos were embedded in
gelatin and cryosectioned to generate 10–12 μm sections of the area of interest.
Sections were mounted on Superfrost® Plus glass slides and the gelatin was
removed by treating the slides in phosphate-buffered saline (PBS) at 37 °C for
15–20 min. The slides were incubated overnight at 4 °C in primary antibody,
diluted in antibody buffer (PBS, 0.1% bovine serum albumen, 0.1% Triton-
X100), followed by incubation for 1–2 h at room temperature in secondary
antibodies diluted in antibody buffer. When biotinylated secondary antibody
was used, slides were further incubated for 1 h at room temperature in Alexa350-
conjugated NeutrAvidin (Molecular Probes/Invitrogen) diluted 1:100 in PBS.
Three 5–10 min washes in PBS followed each incubation. Slides were mounted
in Fluoromount G (SouthernBiotech). Sections were analyzed using epifluor-
escent microscopy; photographs from different channels were superimposed
using Adobe Photoshop or Olympus Microsuite to observe overlapping
expression.
Quantitative analysis
For quantitative analysis of the various markers used after electropora-
tion, two approaches were used. To count Pax3+ targeted cells and analyze
the contribution of targeted cells to the opV ganglion on cryosections of
electroporated embryos, five random sections from the opV (Pax3+)
placode/ganglion region of each embryo were analyzed to minimize varia-
bility and bias. Cells positive for Pax3, GFP or both were determined using
Olympus Microsuite software to identify cells with minimum color
thresholds. In the second approach, used to count targeted cells after in
situ hybridization on wax sections for FGFR4 followed by immunostaining
for Pax3, Islet1 and GFP (when staining was more variable and not all
sections were positive for all three molecular markers), all targeted cells
were counted in the opV placode (Pax3+ and/or FGFR4+) region. The
percentage of cells positive for each marker was calculated for each
embryo, and statistical analysis was performed, with p-values calculatedusing Student's t-test to compare the standard means of control and
experimental samples.
Results
Canonical Wnt signaling is active in Pax3+ opV placode cells
In chick embryos, Pax3 mRNA expression is first seen by in
situ hybridization in ectoderm cells immediately adjacent to the
midbrain-level neural folds at the 4-somite stage (ss) (Stark et
al., 1997), while robust Pax3 protein expression is first
detectable by immunohistochemistry at the 7ss in a similar
location, after which the domain of Pax3 expression expands
laterally into the surface ectoderm away from the neural folds
(Baker et al., 1999). In order to determine whether or not
canonical Wnt signaling is active in Pax3+ opV placode cells,
we co-electroporated a GFP control construct (pCIG-GFP)
together with a modified RFP version of the TOPGAL Wnt
reporter (containing three multimerized LEF/TCF consensus
binding sites) into the surface head ectoderm of 2–11ss chick
embryos, encompassing the trigeminal placode region adjacent
to the midbrain and rostral hindbrain. Nuclear RFP should only
be expressed in cells in which the canonical Wnt signaling
pathway is active. Preliminary results in embryos collected 24 h
after electroporation (26–29ss) clearly showed RFP+ cells in
the opV placode domain (data not shown). Because RFP is very
stable, it was also necessary to analyze embryos at earlier
timepoints in order to determine whether the Wnt pathway is
active during the early stages of placode induction and
throughout opV placode development. Embryos were electro-
porated between the 2–8ss (n=20) with both the RFP Wnt
reporter construct and the control GFP construct, and sacrificed
10–12 h post-electroporation (10–16ss). Whole-mount
embryos showed only a subset of targeted cells (GFP
expression) with activated canonical Wnt signaling (RFP
expression; Figs. 1A–C), indicating that Wnt signaling is only
active in a subset of cranial ectoderm cells, which appear to be
predominantly in the dorsal ectoderm. RFP expression was
visible in a fairly broad region of dorsal head ectoderm adjacent
to the midbrain and rostral hindbrain (Figs. 1B, C), correlating
well with known domains of frizzled (Wnt receptor) expression
(Stark et al., 2000). However, canonical Wnt activity was not
restricted to opV placodal ectoderm, since RFP was observed
generally in dorsal cranial ectoderm, relatively close to the
neural tube. Electroporated embryos were subsequently cryo-
sectioned and immunostained for Pax3, which showed can-
onical Wnt signaling activity in many, though not all, GFP+/
Pax3+ cells (Figs. 1D–K). While we did observe a few RFP+/
Pax3− cells in the opV placode region, the overall pattern
suggests that canonical Wnt signaling is active in opV placode
ectoderm even at early stages of opV placode development.
Canonical Wnt signaling is required for Pax3 expression in the
opV placode
Explant and grafting experiments have previously shown
that significant numbers of cells in midbrain-level opV placode
Fig. 1. Canonical Wnt signaling is active in most Pax3+ ophthalmic trigeminal (opV) placode cells. (A–C) A 14ss chick embryo, 12 h after co-electroporation into
cranial surface ectoderm at the 6ss with GFP (green: A, C) and with a Wnt reporter construct that expresses RFP in response to canonical Wnt signaling (red: B, C).
Canonical Wnt signaling can be seen in a medial subset of electroporated cells (i.e., always relatively close to the neural tube), extending from the rostral midbrain to
the caudal most extent of electroporation (mid-caudal hindbrain). mb, midbrain. (D–G) Transverse section through the opV placode region of a 15ss embryo, 10 h after
electroporation at the 8ss with the RFP Wnt reporter and GFP, showing single-channel (D–F) and merged (G) images of GFP expression (green), RFP/canonical Wnt
activity (red), and Pax3 expression (blue). Only a medial subset of all GFP+ cells are RFP+, i.e., responding to canonical Wnt signaling. (H–K) Higher-power view of
boxed regions in D–G, showing single-channel (H–I) and merged (K) images of GFP expression (green), RFP/canonical Wnt activity (red), and Pax3 expression
(blue). Arrowheads show examples of Pax3+ opV placode cells in which canonical Wnt signaling is active. mb, midbrain; nt, neural tube; ph, pharynx.
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the 8ss onwards (Baker et al., 1999), and that Pax3 expression in
opV placode ectoderm correlates with commitment to a Pax3+
cutaneous sensory neuron fate (Baker and Bronner-Fraser,
2000; Baker et al., 2002). To determine if canonical Wnt
signaling is necessary for opV placode cell development, we
electroporated dominant negative Tcf4 (DN-Tcf; Megason and
McMahon, 2002), which acts as a constitutive repressor of
canonical Wnt targets due to its inability to bind β-catenin, into
cranial ectoderm of 2–6ss embryos (i.e., before significant Pax3
specification/commitment; Baker et al., 1999). Gene expression
from the promoter can typically be observed within 2–3 h after
electroporation (Nakamura et al., 2004), indicating that the
stage at which Wnt signaling is inhibited likely ranges from
about the 4–8ss. GFP was electroporated as a control. Embryos
collected 12 and 24 h post-electroporation, at about the 12ss and
20ss, respectively, were prepared for immunohistochemistry as
described, and sections through the opV placode region were
analyzed in order to characterize GFP+ targeted cells within the
opV placode domain ectoderm.
In GFP-electroporated control embryos, targeted ectoderm
appeared similar to untargeted ectoderm. Within the opV
placode domain, GFP+ targeted cells included many Pax3+
cells as well as several Pax3− cells (Figs. 2A–D). Embryosdisplaying obviously unhealthy tissue morphology were
excluded from the data set, and only embryos where DAPI-
stained nuclei were intact without any apparent degradation
were included. The same stringent criteria were used for DN-Tcf
electroporated experimental embryos, where DN-Tcf was
expressed concomitantly with GFP. In these experimental
embryos, a dramatic loss of GFP+/Pax3+ cells was observed,
confirming that expression of DN-Tcf resulted in cell-autono-
mous loss of Pax3 expression. Untargeted cells within the
placode domain frequently expressed Pax3 (Figs. 2E–H). To
quantify these observations, Pax3+, GFP+, and coexpressing
cells were counted from five random sections through the
placode domain of each electroporated embryo (in order to
compensate for variation in targeting efficiency, and to avoid
experimental bias), and the percentage of targeted cells in the
placode domain coexpressing Pax3 was calculated for each
embryo, and statistical analysis performed, with p-values
calculated using Student's t-test to compare the standard means
of control versus experimental samples. In GFP-electroporated
control embryos targeted at the 2–6ss (n=5) and allowed to
develop for 12 h to about the 12ss, a mean of 61.5% of targeted
cells (S.D.±6.3; 250 total GFP+ cells) from within the placode
domain of each embryo also expressed Pax3. In DN-Tcf-
electroporated embryos (n=6), however, the mean was
Fig. 2. Blocking canonical Wnt signaling leads to loss of Pax3 in the opV placode. (A) Transverse section through the opV placode region of a ∼20ss embryo, 24 h
after electroporation at the 2–6ss with the GFP control vector (green) and immunostaining for Pax3 (red) to identify opV placode cells. (B–D) Single-channel (B, C)
and merged (D) images showing a magnified view of the boxed region in A. Cells targeted with the control plasmid express GFP (green, arrowheads), and continue to
express high levels of Pax3 (red, arrows; overlapping cells shown in yellow in panel D). (E) Transverse section through the opV placode region of a ∼22ss embryo,
24 h after electroporation at the 2–6ss with dominant negative Tcf4 (DN-Tcf; GFP+ cells in green) and immunostaining for Pax3 (red). (F–H) Single-channel (F, G)
and merged (H) images showing a magnified view of the boxed region in E. GFP+ cells targeted with DN-Tcf show a cell-autonomous loss of Pax3 (arrowheads);
adjacent untargeted cells express Pax3 at normal levels (arrow). (I) Histograms showing the percentage of targeted cells expressing Pax3 in control embryos (blue) and
DN-Tcf-electroporated embryos (yellow). Embryos electroporated at the 2–6ss were allowed to develop for 12 or 24 h to about the 12ss and 20ss, respectively;
embryos electroporated at the 10–14ss were collected after 12 h at about the 20ss. Sample size for each experiment is indicated. The dramatic reduction in Pax3
expression in DN-Tcf-electroporated embryos compared to controls is highly statistically significant at all timepoints (pb0.0001; *). The reduction in Pax3+ cells in
embryos electroporated at the 10–14ss shows a highly statistically significant reduction compared to control embryos (pb0.0001); however, a less dramatic reduction
compared to embryos electroporated with DN-Tcf at the 2–6ss was observed (pb0.05; **).
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total GFP+ cells), a difference that is highly statistically
significant compared to controls (pb0.0001; Fig. 2I). Similarly,
DN-Tcf-electroporated embryos allowed to develop 24 h (to
approximately the 20ss) showed a highly statistically significant
reduction when compared to controls. A mean of 60.4% of
targeted cells (S.D.±18.2; 280 total GFP+ cells) per control em-
bryo (n=8), also expressed Pax3, versus a mean of 3.5% (S.D.±
2.5; 430 total GFP+ cells) in DN-Tcf-electroporated embryos
(n=10, pb0.0001; Figs. 2A–I). Therefore, blocking canonical
Wnt signaling in the opV placode by electroporating DN-Tcf at
the 2–6ss led to a highly statistically significant reduction of
Pax3 expression in targeted cells, detectable at both 12 and 24 h
after electroporation.
To investigate the effects of blocking Wnt signaling in opV
placode cells later in development (i.e., after significant
numbers of opV placode cells are specified and/or committed
to express Pax3), 10–14ss embryos were electroporated as
described, and allowed to develop for 12 h to about the 20–
22ss, the same stage as the 2–6ss embryos described above,
which were allowed to develop for 24 h. In GFP-electroporated
control embryos (n=6), a mean of 61.9% of targeted cells
(S.D.±4.1; 426 total GFP+ cells) in each embryo expressed
Pax3, similar to younger control embryos. Although many cells
in the targeted region are already expressing Pax3 and/or
committed to express Pax3 at the time of electroporation, the
mean percentage of targeted cells expressing Pax3 wasunexpectedly reduced in DN-Tcf electroporated embryos
(n=6), to only 14.6% (S.D.±8.8; 246 total GFP+ cells), a
difference highly significant from controls (pb0.0001; Fig. 2I).
This indicates that canonical Wnt signaling is necessary to
maintain Pax3 expression in the opV placode. Interestingly,
this reduction was not as dramatic as that observed in embryos
electroporated at the 2–6ss, before significant numbers of cells
are committed to express Pax3 (3.5% compared to 14.6%
coexpressing cells after 12 h; statistically significant, pb0.05),
pointing to potential differences in the effects of blocking Wnt
signaling before and after cell specification.
Canonical Wnt signaling is not sufficient to induce Pax3 in
the opV placode
To determine if Wnt signaling is sufficient to induce the opV
placode cell fate in cranial ectoderm cells, we electroporated a
dominant-active form of β-catenin (DA-βcat), which is
resistant to proteolysis and therefore constitutively activates
the Wnt pathway (Megason and McMahon, 2002), into head
and rostral trunk ectoderm of 2–11ss embryos. After electro-
poration, embryos were allowed to develop for 24 h to about the
20ss before being photographed for GFP expression, and
prepared for in situ hybridization or immunohistochemistry as
described.
Whole-mount in situ hybridization for Pax3 revealed that
the Pax3 expression domain did not expand concomitant with
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adjacent to rhombomeres 2–4 (Baker et al., 1999) was targeted
(Figs. 3B, C). To ensure that the DA-βcat construct is indeed
activating the Wnt pathway, DA-βcat was co-electroporated
with the RFP Wnt reporter. Embryos electroporated with DA-
βcat and Wnt reporter showed a near complete overlap of GFP
and RFP expression (n=6; Fig. 3E), whereas embryos co-
electroporated with the control GFP and RFP Wnt reporter
(n=6; Fig. 3D) produced only limited overlapping expression,
indicating that DA-βcat successfully activated the Wnt path-
way. To confirm that DA-βcat did not increase Pax3
expression, and to determine whether DA-βcat misexpression
biased cells within the placode domain toward Pax3 expres-
sion, sections through the opV placode and adjacent regions
were analyzed to identify Pax3+ cells and GFP/DA-βcat
expressing cells within the ectoderm. Misexpression of DA-
βcat in competent cranial ectoderm did not result in an
increase in the number of targeted cells expressing Pax3 when
compared to controls, neither within the placode domain (Figs.
4A–H) nor in sections through adjacent ectoderm (data not
shown). In control embryos (n=10), the mean percentage per
embryo of GFP+ opV placode cells that expressed Pax3 was
66.4% (S.D.±10.8; 1000 total GFP+ cells), while in experi-
mental embryos, the mean was effectively the same, at 68.3%Fig. 3. Canonical Wnt signaling does not expand Pax3 expression outside the
opV placode region. (A) In situ hybridization for Pax3, showing normal Pax3
expression in the opV placode. (B–C) 23ss embryo, 24 h after electroporation at
the 5–9ss with dominant active β-catenin (DA-βcat), showing a similar pattern
of Pax3 expression as the control (B) even after broad ectodermal targeting with
DA-βcat, visualized by epifluorescent microscopy for GFP (C). (D, E) Positive
control showing that DA-βcat activates the Wnt pathway in the opV placode
region. (D) Transverse section through the head region of a ∼20ss embryo, 24 h
after co-electroporation with the GFP control vector (green) and the Wnt RFP
reporter (red) at the 5–9ss. A restricted pattern of Wnt activity (RFP expression)
is seen, with many targeted green cells not activating the Wnt pathway.
(E) Transverse section through the head region of a ∼23ss embryo, 24 h after
co-electroporation with DA-βcat (green) and the Wnt RFP reporter (red) at the
5–9ss. Nearly all of the targeted cells are also expressing RFP, confirming that
the DA-βcat construct is indeed activating the Wnt pathway (ov, otic vesicle).(S.D.±7.7; 830 total GFP+ cells; Fig. 4I). Therefore, no
significant difference between control and experimental em-
bryos was observed after ectopically activating Wnt signaling
in the opV placode domain.
To rule out the possibility that endogenous placode induction
cues were masking the effect of DA-βcat misexpression (so as
to test conclusively that Wnt signaling is not sufficient to induce
Pax3), we blocked signaling from the neural tube using
tantalum foil barriers (Stark et al., 1997) and misexpressed
DA-βcat in adjacent ectoderm to look for rescue of Pax3
expression (Fig. 5; n=15). We did not observe a significant
rescue of Pax3 in targeted ectoderm, supporting the conclusion
that canonical Wnt signaling is not sufficient for opV placode
induction. Since we had now shown that Wnt signaling was
required for Pax3 expression, but could not induce it on its own,
we next examined more thoroughly the effects of DN-Tcf on
opV placode cell differentiation.
Canonical Wnt signaling is required for opV placode cell
delamination and contribution to the ganglion
To assess opV ganglion formation after blocking canonical
Wnt signaling, we electroporated DN-Tcf into 2–6ss embryos,
and allowed them to develop for 48 h to about 35ss, when the
ganglion is becoming well-defined. Embryos were analyzed by
counting the number of GFP+/Pax3+ cells in each embryo
compared to the total number of Pax3+ cells (targeted and
untargeted) in the ganglion on five randomly selected sections
through the opV placode/ganglion region of each embryo.
(Although some neural crest cells express Pax3 at very low
levels, opV placodal Pax3 expression is much higher and thus
easily distinguishable from neural crest expression in migrating
cells and in the ganglion.) This analysis allowed us to determine
the proportion of all Pax3+ cells in the ganglion that
coexpressed GFP in control and experimental embryos.
Qualitative analysis of these sections showed that after control
GFP electroporation, many GFP+ cells contributed to the
ganglion (Fig. 6A), while after DN-Tcf electroporation, nearly
all of the GFP+/DN-Tcf-expressing cells remained in the
ectoderm, with no contribution to the opV ganglion (Fig. 6B).
Because of the near absence of GFP+ ganglionic cells in DN-
Tcf electroporated embryos, cell counts were performed
differently, where all Pax3+ cells were counted, and the
percentage of those cells expressing GFP was compared
between control and experimental embryos: in control embryos
(n=5), the mean percentage per embryo of Pax3+ ganglionic
cells that coexpressed GFP was 47.9% (S.D.±5.2; 1158 total
Pax3+ cells), while in DN-Tcf-electroporated embryos (n=3),
the mean was only 1.1% (S.D.±0.3; Fig. 6C; 285 total Pax3+
cells). Thus, electroporating DN-Tcf into the opV placode at the
2–6ss led to a highly statistically significant reduction in the
contribution of targeted cells to the ganglion (pb0.005; Fig.
6C). Importantly, though targeted cells in experimental embryos
did not contribute to the ganglion, and did not express Pax3, the
opV ganglion still contained many Pax3+/GFP− placode cells
(Fig. 6B; an average of 95 Pax3+ cells per DN-Tcf electro-
porated embryo, compared to an average of 193 Pax3+ cells per
Fig. 4. Activating Wnt signaling does not increase the number of Pax3+ cells in the opV placode. (A) Transverse section through the opV placode of a ∼25ss embryo,
24 h after electroporation with the GFP control vector (green) at the 5–9ss, immunostained for Pax3 (red). (B–D)Magnified view of boxed region in A showing single-
channel (B, C) and merged (D) images. Cells targeted with control vector express GFP (arrowheads). Many cells within the placode domain also express high levels of
Pax3 (arrows; overlapping cells shown in yellow in D; flanked by arrow/arrowhead). (E) Transverse section through the opV placode of a ∼25ss embryo, 24 h after
electroporation with dominant active β-catenin (DA-βcat; green) at the 5–9ss, immunostained for Pax3 (red). (F–H) Magnified view of boxed region in E showing
single-channel (F, G) and merged (H) images. GFP+ cells targeted with DA-βcat are prevalent (arrowheads), as are cells expressing high levels of Pax3 (arrows;
overlapping cells shown in yellow in H; flanked by arrow/arrowhead). (I) Histogram showing the percentage of targeted ectodermal cells expressing Pax3 in control
embryos and DA-βcat-electroporated embryos. The difference between the two is not statistically significant.
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placodal competence at early stages.
We showed above that DN-Tcf electroporation at the 10–
14ss, when significant numbers of cells in midbrain-level opV
placode ectoderm are already specified and committed to
express Pax3, results in a dramatic loss of Pax3-expressing
ectoderm cells within 12 h. To investigate ganglion develop-
ment under these conditions, we electroporated DN-Tcf into the
head ectoderm of 10–14ss embryos, which were allowed to
develop for 30–36 h to about the 35ss, when the ganglion
becomes well defined. We found that blocking Wnt signaling inFig. 5. Activating Wnt signaling does not rescue loss of Pax3 in opV placode ectod
collected 24 h after being electroporated at the 2–6ss with dominant active β-catenin (
was placed unilaterally between the neural tube and adjacent ectoderm to block the di
A, under epifluorescence microscopy following removal of the barrier, showing the e
placode region showing GFP (green) and Pax3 expression (red). A dramatic reductio
seen, as shown previously (Stark et al., 1997); there was no rescue by DA-β-catenin,
line indicates barrier location. ov, otic vesicle).older embryos, where cells are apparently already expressing
and/or committed to express Pax3, not only led to the loss of
Pax3 expression but also to the failure of targeted cells to
contribute to the ganglion (Fig. 6E). Again, all Pax3+ cells were
counted, and the percentage of those cells expressing GFP was
compared between control and experimental embryos and
statistical analysis performed, with p-values calculated using
Student's t-test as described. In control embryos (n=5), the
mean percentage per embryo of Pax3+ cells in the ganglion that
coexpressed GFP was 39.0% (S.D.± 18.8; 700 total Pax3+
cells; Figs. 6D, F), while in experimental embryos (n=7), theerm after blocking the Pax3-inducing signal from the brain. (A) ∼20ss embryo
DA-βcat) and in which, immediately after electroporation, a tantalum foil barrier
ffusible Pax3-inducing signal from the neural tube. (B) Same embryo as in panel
xtent of the GFP/DA-βcatenin expression domain. (C) Section through the opV
n in the number of Pax3-expressing opV placode cells lateral to the barrier was
as evidenced by the many GFP+/Pax3-negative cells lateral to the barrier (white
Fig. 6. Blocking canonical Wnt signaling prevents targeted cells from delaminating and contributing to the opV ganglion. (A) Transverse section through opV ganglion
region of a ∼35ss embryo, 48 h after electroporation at the 2–6ss with the GFP control vector (green), immunostained for Pax3 (red). GFP+ cells contribute
substantially to the opV ganglion, with numerous cells expressing both GFP and Pax3 (yellow). (B) Transverse section through opV ganglion region of a ∼35ss
embryo, 48 h after electroporation at the 2–6ss with DN-Tcf (green) and immunostained for Pax3 (red). Virtually all GFP+ cells remain in the ectoderm, do not express
Pax3, and do not contribute to the ganglion, though a significant number of untargeted Pax3+ ganglionic cells are present. (C) Histogram showing the percentage of
Pax3+ opV ganglion cells that were also targeted (GFP+) in control (n=5) versus DN-Tcf embryos (n=3). The dramatic reduction in the contribution of DN-Tcf-
targeted cells to the ganglion is highly statistically significant (pb0.005). (D) Transverse section through opV ganglion region of a ∼35ss embryo, 36 h after
electroporation at the 10–14ss with the GFP control vector (green), immunostained for Pax3 (red). Targeted cells contribute substantially to the opV ganglion, with
numerous cells expressing both GFP and Pax3 (yellow). (E) Transverse section through opV ganglion region of a ∼35ss embryo, 36 h after electroporation at the 10–
14ss with DN-Tcf (green), immunostained for Pax3 (red). DN-Tcf-targeted cells remain in the ectoderm and do not express Pax3. Unlike in embryos targeted earlier in
development (as in B), very few untargeted Pax3+ cells are present in the ganglion. (F) Histogram showing the percentage of Pax3+ cells within the ganglion
coexpressing GFP in control (n=5) versus DN-Tcf embryos (n=7). The dramatic reduction in the contribution of DN-Tcf-targeted cells to the ganglion is statistically
significant (pb0.02).
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F). (In separate experiments, a similarly significant reduction
was seen in the percentage of targeted cells that had delaminated
from the ectoderm 24 h after electroporation of 10–14ss
embryos; data not shown.) Thus, electroporating DN-Tcf into
the opV placode at the 10–14ss led to a statistically significant
reduction in the contribution of targeted cells to the ganglion
(pb0.02). Importantly, we also observed that the overall
placodal contribution to the opV ganglion was significantly
reduced, with a dramatic reduction in the total number of Pax3+
cells (targeted or untargeted) contributing to the ganglion (an
average of 25 Pax3+ cells per DN-Tcf electroporated embryo,
compared to an average of 140 Pax3+ cells per control embryo).
This effect was in contrast to what was seen after electroporating
DN-Tcf at the 2–6ss, where untargeted cells were prevalent inthe ganglion (50% compared to controls when targeting at the 2–
6ss; 18% compared to controls when targeting at the 10–14ss).
Canonical Wnt signaling is required for opV placode
differentiation
As described above, blocking canonical Wnt signaling in
the opV placode region leads to the loss of Pax3 expression,
and the failure of targeted cells to delaminate from the ecto-
derm and contribute to the opV ganglion. The next question
was whether DN-Tcf targeted opV placode cells indeed fail
to differentiate as opV neurons, or whether they differ-
entiate normally but simply fail to delaminate. To answer
this, we analyzed expression of both the opV placode-spe-
cific marker FGF receptor 4 (FGFR4, previously known as
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after Pax3 in opV placode cells (Stark et al., 1997), and the early
neuronal differentiation marker Islet1 (Ericson et al., 1992;
Mulder et al., 1995). We performed in situ hybridization for
FGFR4 on sections of embryos electroporated at 5–6ss and
allowed to develop for 24 h (to the 21–27ss), followed by
immunostaining for Pax3, Islet1, and GFP (native GFP
fluorescence is lost after in situ hybridization). Due to the
variability in staining from in situ hybridization and analyzing
multiple markers, all GFP+ cells in the opV placode region of
each embryo were counted from well-stained sections as
described, resulting in several hundred GFP+ cells being
counted for both experimental (DN-Tcf) and control (GFP)
embryos. A minimum of six individual placodes/ganglia were
analyzed for each marker (placodes/ganglia with targeted cells
on both sides of the same embryo were counted independently).
We found that DN-Tcf expressing opV placode cells, as well as
being significantly less likely to express Pax3 and delaminate
from the ectoderm, were significantly less likely to express the
opV placode-specific marker FGFR4, 24 h after electroporation
at the 5–6ss (Fig. 7). In GFP-electroporated embryos, the mean
percentage per placode of targeted cells that coexpressed
FGFR4 was 26.9% (S.D.±12.3; 305 total GFP+ cells; n=6
from 5 embryos). In DN-Tcf-electroporated embryos, the meanFig. 7. Blocking canonical Wnt signaling blocks FGFR4 expression in opV placode c
at the level of the opV placode in a 20ss embryo in which the control GFP plasmid ha
hybridization on sections for FGFR4 (C) and immunostaining for GFP (green, A) an
FGFR4 and Pax3. (E–H) Single-channel (E–G) and merged (H) images of a transver
been electroporated into cranial surface ectoderm at the 6ss, followed by in situ hybri
Pax3 (red, F). Arrows indicate examples of DN-Tcf-targeted (GFP+) opV placode cel
delaminated. All of the Pax3+ cells that have delaminated, many of which are alsoper placode was only 3.7% (S.D.±4.1; 473 total GFP+ cells;
n=7 from 4 embryos), a highly statistically significant reduction
(pb0.0005; Student's t-test).
The transcription factor Islet1, which is expressed early in
the differentiation of various neuronal subtypes (Ericson et al.,
1992; Mulder et al., 1995) is expressed in the opV placode from
the 17ss, and marks differentiating opV neurons both in the
ectoderm and in the opV ganglion. We found that blocking
canonical Wnt signaling led to a significant reduction in the
proportion of targeted cells expressing Islet1 24 h after
electroporation. In GFP-electroporated embryos, the mean
percentage per placode/ganglion of targeted cells that coex-
pressed Islet1 was 14.5% (S.D.±13.8; 449 total GFP+ cells;
n=7 from 6 embryos). In DN-Tcf-electroporated embryos, the
mean was only 4.7% (S.D.±7.7; 844 total GFP+ cells; n=11
from 7 embryos), a statistically significant reduction (pb0.05,
Student's t-test; Figs. 10A–J).
Older embryos electroporated with DN-Tcf between the 10–
14ss and collected at approximately the 35ss, during ganglion
condensation, were also analyzed for the presence of neuronal
differentiation markers normally found in opV ganglion cells
(neurofilament, and the neuron-specific neuronal antigen NeuN;
Mullen et al., 1992). As in previous experiments, DN-Tcf
targeted GFP cells remained in the ectoderm, and although theells. (A–D) Single-channel (A–C) and merged (D) images of a transverse section
d been electroporated into cranial surface ectoderm at the 5ss, followed by in situ
d Pax3 (red, B). Arrowheads indicate GFP-electroporated cells expressing both
se section at the level of the opV placode in a 27ss embryo in which DN-Tcf had
dization on sections for FGFR4 (G) and immunostaining for GFP (green, E) and
ls that do not express either FGFR4 or Pax3; interestingly, two of these cells have
detectably FGFR4, are untargeted.
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ganglion, none of the targeted cells (in all embryos analyzed)
expressed NeuN (0/5 embryos) or neurofilament (0/4 embryos;
Figs. 8A, B).
Therefore, blocking canonical Wnt signaling in opV
placodal ectoderm by electroporation of DN-Tcf leads not
only to a significant reduction in Pax3 expression, delamina-
tion, and contribution to the ganglion, but also to a sig-
nificant reduction both in the expression of the downstream
opV placode-specific marker FGFR4 and in neuronal di-
fferentiation, as assessed by Islet1, NeuN, and neurofilament
expression.
Blocking canonical Wnt signaling does not upregulate markers
of other placodes
Throughout all stages and time points tested, the great
majority of DN-Tcf targeted cells remain in the ectoderm. To
address the possibility that these cells may be adopting a
different placodal fate, we analyzed DN-Tcf electroporated
embryos for the expression of Pax2, which marks the
epibranchial as well as the otic placodes in the chick (Baker
and Bronner-Fraser, 2000), and Pax6, which marks the lens
placode (see Bhattacharyya et al., 2004). Immunohistochem-
istry on sections through the head region show that DN-Tcf
targeted cells did not upregulate Pax2 (0/4 embryos) or Pax6 (0/
6 embryos) in any of the embryos tested (Figs. 8C, D).Fig. 8. OpV placode cells targeted with DN-Tcf do not differentiate as neurons
and do not express other placodal markers. (A–D) Transverse sections through
the opV ganglion of embryos electroporated with DN-Tcf between the 10–14ss
and allowed to develop to approximately the 35ss. Themajority of targeted GFP+
cells remained in the ectoderm and did not delaminate or contribute to the opV
ganglion. They did not express either (A) the post-mitotic neuronal antigen
NeuN; (B) the neuronal marker neurofilament; (C) the otic and epibranchial
placode marker Pax2; (D) or the lens placode marker Pax6.Canonical Wnt signaling is required to maintain expression
of Eya2 in the opV placode
We also investigated whether blocking the Wnt signaling
pathway affects markers expressed generally in all cranial
placodes. In the chick, Eya2 is expressed in the preplacodal
domain (a horseshoe-shaped region of ectoderm surrounding
the anterior neural plate at the neurula stage; Litsiou et al.,
2005) and is maintained in placode derivatives, including
cranial sensory ganglia (Mishima and Tomarev, 1998).
Expression of Eya2 in the chick preplacodal domain at neurula
stages requires inhibition of canonical Wnt signaling (Litsiou
et al., 2005), so it might be predicted that blocking Wnt
signaling at later stages might upregulate Eya2 expression in
the opV placode. We used in situ hybridization on sections of
electroporated embryos, followed by immunostaining for
Pax3, Islet, and GFP, to investigate this possibility. We found
that 24 h after electroporating 6ss embryos with the DN-Tcf
construct (n=3), targeted cells within the opV placode region
appeared to downregulate Eya2 as compared to their
untargeted neighbors (Fig. 9). Although only qualitative,
these results do not support the hypothesis that blocking
canonical Wnt signaling at early somite stages prevents opV
placode cells from progressing beyond a pre-placodal state.
Instead, they suggest that canonical Wnt signaling is required
to maintain the expression not only of Pax3 itself, and the
downstream opV placode-specific marker FGFR4, but also of
the pan-placodal marker Eya2. Overall, these results suggest
that canonical Wnt signaling is required to maintain all aspects
of the opV placode fate.
Blocking canonical Wnt signaling upregulates Neurogenin2
expression in all embryonic ectoderm
We also used in situ hybridization on sections of elec-
troporated embryos, followed by immunostaining for Pax3,
Islet, and GFP, to assess the effect of blocking canonical Wnt
signaling on the expression of Neurogenin2 (Ngn2), a
proneural transcription factor expressed early in the neurogenic
cascade in specific subsets of sensory neurons (Fode et al.,
1998; Ma et al., 1998). Ngn2 begins to be expressed in the
opV placode from as early as the 10ss in the chick, where it
has been described as a specific marker for opV placode-
derived neurons, with Ngn1 being expressed in all other
neurogenic placodes (Begbie et al., 2002). However, at later
stages than those analyzed by Begbie et al. (2002), we found
that Ngn2 is expressed in all placode-derived neurons in the
chick (data not shown), so it is not in fact a specific marker for
opV placode neurons, but rather a more general marker for
placode-derived sensory neurons.
In stark contrast to the downregulation of opV placode
markers (Pax3, FGFR4, Eya2) and neuronal differentiation
markers (Islet1, neurofilament and NeuN) that we previously
saw after electroporating DN-Tcf, we found that, 24 h after
electroporating DN-Tcf at the 5–7ss (n=5), seemingly all
targeted cells dramatically upregulated expression of Ngn2
(Figs. 10F–J). No effect was seen on Ngn2 expression in the
Fig. 9. Blocking canonical Wnt signaling blocks expression of the pan-placodal marker Eya2 in opV placode cells. (A) Merged image of a transverse section at the
level of the opV placode in a 19ss embryo in which GFP had been electroporated into cranial surface ectoderm at the 5ss, followed by in situ hybridization on sections
for Eya2 and immunostaining for GFP (green). (B–D) Single-channel (B, C) and merged images (D) of higher-power view of boxed region in A. Arrowheads show
examples of GFP-targeted ectoderm cells expressing Eya2. (E) Merged image of a transverse section at the level of the opV placode in an 18ss embryo in which DN-
Tcf had been electroporated into cranial surface ectoderm at the 6ss, followed by in situ hybridization on sections for Eya2 and immunostaining for GFP (green). (F–
H) Single-channel (F, G) and merged images (H) of higher-power view of boxed region in E. Arrowheads delimit region of Eya2 expression in untargeted ectodermal
cells, bounded both dorsally and ventrally by Eya2-negative DN-Tcf-targeted ectoderm (nt, neural tube; ph, pharynx).
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GFP (Figs. 10A–E). Intriguingly, the upregulation of Ngn2
after DN-Tcf expression was not confined to the opV placodal
area, nor even to cranial ectoderm, since a similar upregulation
was seen even in trunk ectoderm (Figs. 10L–O), where
electroporation of GFP alone had no effect (n=5). These results
are perhaps even more surprising in light of the failure of DN-
Tcf-targeted cells to differentiate as neurons, given that Ngn2
misexpression (using retroviruses) in the chick trunk has
previously been shown to lead to neuronal differentiation
even in non-ectodermal cells (Perez et al., 1999).
Discussion
Canonical Wnt signaling is necessary, but not sufficient,
for adoption of an opV placode cell fate
The combined work of Stark et al. (1997) and Baker et al.
(1999), through various barrier, grafting, and explant experi-
ments, supported a model for ophthalmic trigeminal (opV)
placode induction in which all cranial ectoderm is initially
competent to express Pax3 in response to a diffusible inducing
signal from the dorsal neural tube, with spatiotemporal changes
in competence contributing to the restriction of Pax3 expression
in the opV placode adjacent to the midbrain and rostral
hindbrain. Over a 36-h period from the 4-somite stage (ss)
onwards, cells in the opV placode domain upregulate first Pax3,
then FGFR4 and Ngn2, delaminate from the ectoderm and
differentiate as sensory neurons in the condensing ophthalmic
lobe of the trigeminal ganglion (Stark et al., 1997; Baker et al.,
1999; Begbie et al., 2002). Pax3 expression is maintained at
high levels in opV placode-derived neurons until some point
between E4.5 and E5.5 (Baker et al., 2002).Until now, the signaling pathways required for opV placode
development were unknown, although a possible role for Wnt
signaling was suggested by reduction of the opV nerve inWnt-1
null (though not Wnt-3a null) mice (Ikeya et al., 1997), and a
rostral expansion of trigeminal neurons in zebrafish mutants in
which the canonical Wnt pathway is over-activated (Kim et al.,
2000). The dorsal neural tube expresses Wnt-1, Wnt-3a, and
Wnt4 (Hollyday et al., 1995; Marcelle et al., 1997), and Wnt
receptors (frizzleds) are present in cranial ectoderm (Stark et al.,
2000). The RFP Wnt reporter results presented here show that,
in the chick embryo, canonical Wnt signaling is active in dorsal
cranial ectoderm near the neural tube, including Pax3+ opV
placode cells. Blocking canonical Wnt signaling before the 8ss,
i.e., before significant numbers of ectoderm cells are specified
and committed to express Pax3 (Baker et al., 1999), disrupts
opV placodal Pax3 expression. Regardless of how long
embryos were allowed to develop after electroporation (12,
24, or 48 h), dramatically fewer targeted cells expressed Pax3 or
delaminated in embryos electroporated with dominant negative
Tcf4 (DN-TCF) compared to controls. This is likely due to
either a failure of targeted cells to upregulate Pax3 (loss of
induction), or a rapid downregulation of initial Pax3 expression
(immediate loss of maintenance).
In addition to the observed loss of Pax3 and failure of
targeted cells to delaminate, blocking canonical Wnt signaling
before the 8ss also led to a clear reduction in expression of the
opV placode-specific marker FGFR4 (expressed after Pax3 in
the opV placode; Stark et al., 1997), the general placodal marker
Eya2 (expressed at neurula stages in preplacodal ectoderm and
maintained in placode-derived cells; see Litsiou et al., 2005;
Bailey and Streit, 2006), and the early neuronal differentiation
marker Islet1. In addition, expression of the later neuronal
differentiation markers neurofilament and NeuN was never
Fig. 10. Blocking canonical Wnt signaling blocks neurogenesis in opV placode-derived cells but upregulates Ngn2 expression, both in opV placode cells and other
regions of ectoderm, including trunk ectoderm. (A–E) Single-channel (A–D) and merged (E) images of a transverse section at the level of the opV placode in a 26ss
embryo in which the control GFP vector had been electroporated into cranial surface ectoderm at the 7ss, followed by in situ hybridization on sections for Ngn2 (D)
and immunostaining for GFP (green, A), Pax3 (red, B), and the early neuronal differentiation marker Islet1 (blue, C). Arrowheads indicate examples of GFP-targeted
opV placode cells that express both Ngn2 and Pax3 in the ectoderm, and Ngn2, Pax3, and Islet1 in the adjacent opV placode-derived ganglion. (F–J) Single-channel
(F–I) and merged (J) images of a transverse section at the level of the opV placode in a 26ss embryo in which DN-Tcf had been electroporated into cranial surface
ectoderm at the 6ss, followed by in situ hybridization on sections for Ngn2 (I) and immunostaining for GFP (green, F), Pax3 (red, G), and Islet1 (blue, H). Strong Ngn2
expression, but no Pax3 expression, is seen in all DN-Tcf-targeted cells in the ectoderm (arrows indicate examples), immediately ventral to Pax3+ untargeted ectoderm
cells. Some untargeted Pax3+Islet1+ neurons, many of which are also detectably Ngn2+, have delaminated from the ectoderm. (K) Merged view of a transverse
section through the trunk of a 28ss embryo in which the control GFP vector had been electroporated into surface ectoderm at the 10ss, followed by in situ hybridization
on sections for Ngn2 and immunostaining for GFP (green), showing normal Ngn2 expression in the neural tube (nt) but no staining in the surface ectoderm. (L)
Transverse section through the trunk of a 19ss embryo in which DN-Tcf had been electroporated into surface ectoderm at the 10ss, followed by in situ hybridization on
sections for Ngn2, showing ectopic Ngn2 expression in surface ectoderm as well as the normal Ngn2 expression pattern in the neural tube (nt). (M–O) Single-channel
(M, N) and merged (O) magnified views of boxed region in L, showing Ngn2 expression (N) in Dn-Tcf-targeted cells (green, M). The Ngn2 staining is so strong in
some cells that it has masked the GFP immunofluorescence (nt, neural tube).
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hypothesis that canonical Wnt signaling is required for opV
placode cell differentiation. However, activation of canonical
Wnt signaling with dominant active β-catenin (DA-β-cat) had
no effect on the number of targeted cells expressing Pax3 in the
ectoderm, either within the opV placode domain or in nearby
ectoderm, indicating that Wnt signaling alone is not sufficient to
induce Pax3. Even when a barrier was placed between the
neural tube and ectoderm to block endogenous inductive
signaling, activation of canonical Wnt signaling was not able
to rescue Pax3 expression. Hence, although canonical Wnt
signaling is required for adoption of an opV placode fate, it does
not induce Pax3, the earliest marker for the opV placode.
Canonical Wnt signaling is necessary to maintain an opV
placode fate
From the 8ss, a substantial number of ectoderm cells at the
level of the midbrain are specified and committed to express
Pax3 and to adopt a Pax3+ cutaneous sensory neuron fate, as
determined by explant and heterotopic grafting experiments(Baker et al., 1999, 2002; Baker and Bronner-Fraser, 2000). We
found that electroporating DN-Tcf at the 10–14ss, when a
significant number of opV placode cells already express Pax3,
also resulted in the downregulation of Pax3 and the failure of
targeted cells to delaminate, just as was observed in embryos
targeted at the 2–6ss. By inhibiting canonical Wnt signaling
late, therefore, we were able to alter the fate of opV placode
cells that were already apparently committed (in heterotopic
grafting experiments) to express Pax3 and adopt an opV
placode cell fate. Hence, canonical Wnt signaling is required to
maintain Pax3 expression, and also to allow delamination and
contribution to the ophthalmic lobe of the trigeminal ganglion.
Given that Wnt signaling is required to maintain Pax3
expression in opV placode cells, how then can we explain the
previous specification and commitment data obtained through
explant and heterotopic grafting experiments? One might predict
from the data presented here that Pax3+ opVectoderm cells would
lose Pax3 expression in neutral culture conditions (specification
test), and possibly also after grafting to a heterotopic location
(commitment test, in this case, grafting over the lateral plate
mesoderm or to the nodose placode; Baker et al., 1999, 2002;
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were also present in the grafted location. There are at least two
possible explanations for the maintenance of Pax3 expression in
the specification test. First, Wnts may be expressed in the
explanted ectoderm itself, thus autocrine signaling would
maintain Pax3 expression. Second, Wnt signaling may be
required tomaintain Pax3 expression in the presence of alternative
specification cues in the cranial environment, so in explant
culture,Wnt signals would no longer be required tomaintain Pax3
expression. Future experiments aimed at examining the expres-
sion ofWnt familymembers, and the response of cranial ectoderm
tissue to various candidate signaling factors, will resolve this
question.
Although DN-Tcf-targeted cells remained in the ectoderm
and did not express Pax3 in either the early (2–6ss) or late (10–
14ss) Wnt inhibition experiments, there was a significant
reduction in the total number of untargeted Pax3+ placode cells
contributing to the ganglion after electroporation at later stages,
relative to the significant compensation seen after electropora-
tion at early stages. This suggests that, after DN-Tcf electro-
poration at the 10–14ss, neighboring untargeted cells have
either lost competence to express Pax3, or that the Pax3-
inducing signal is no longer present when Wnt activity is
blocked. Some support for the latter hypothesis is provided by
previous grafting experiments, which suggested that the Pax3-
inducing signal at the midbrain level may decline after the 8ss
(Baker et al., 1999). This is well before the stage at which Wnt
signaling is blocked in this study, which is likely to be 2–3 h
after electroporation, perhaps at the 12–16ss. Conversely,
sufficient inducing activity must be present (perhaps from the
rostral hindbrain or midbrain/hindbrain junction) through at
least the 12ss, since previous ablation experiments showed that
when presumptive opV placodal ectoderm in 12ss embryos was
removed and embryos were allowed to develop to a stage of
ganglion condensation, opV placode cells were still present,
albeit reduced in number, with the majority of remaining cells
condensing external to the ganglion (Stark et al., 1997).
Whether due to a loss of competence or a loss of the inducing
signal, our results suggest that much of the cellular plasticity of
opVand nearby cranial ectoderm is lost by a few hours after the
10–14ss.
Upregulation of Ngn2 in response to DN-Tcf
The observation that Ngn2, which is expressed at some stage
in all placode-derived neurons, is dramatically upregulated in all
embryonic ectoderm (including trunk ectoderm) after DN-Tcf
electroporation may seem contradictory to other data presented
here. A simple model may include a regulatory loop between
Pax3 and Ngn2. A recent study has revealed a dynamic
interplay between Pax6 and Ngn2 in the stepwise process of
neurogenesis in the spinal cord (Bel-Vialar et al., 2007). Their
data showed that Pax6 acts as one player in upregulating Ngn2
expression, and subsequent high levels of Ngn2 initiate the
downregulation of Pax6, which is necessary for neuronal
differentiation. In contrast, Pax3 expression is maintained for
several days in differentiated opV placode-derived neurons(Baker et al., 2002), so a similar model (i.e., Ngn2-mediated
downregulation of Pax3) cannot apply during normal opV
placode development.
An alternative scenario is the direct regulation of Ngn2 by
the Wnt pathway. Several studies indicate that the regulation of
Neurogenin gene expression by β-catenin/Tcf is context-
specific. Upstream regulatory regions of Ngn1, for example,
have known binding sites for Lef/Tcf, and the β-catenin/Tcf
complex has been shown to bind these regulatory elements
(Hirabayashi et al., 2004). One study showed that while Lef/Tcf
activation sites were confirmed in the promoter regions of
neurogenins, β-catenin itself is likely able to bind the Ngn1
promoter region directly, independent of Lef/Tcf (Israsena et al.,
2004). Additional studies have concluded that, depending on
the presence of cofactors such as FGF2, and on the state of
cellular differentiation, Wnt signaling can enhance cell
proliferation, promote differentiation, or inhibit differentiation
of neuronal precursor cells (Hirabayashi et al., 2004; Muroyama
et al., 2004). It has also been shown that antagonizing Wnt
signaling upregulates Ngn2, and that, under various cellular
contexts, β-catenin/Tcf may act as a repressor or an activator of
Ngn1 (Aubert et al., 2002; Kubo et al., 2005). Our results
support these and other observations describing the complex
interplay between various signal transduction pathways that
converge during the several stages of cellular differentiation
during neurogenesis. While introducing DN-Tcf clearly down-
regulated most developmental markers of the opV placode,
Ngn2 was unexpectedly upregulated even in the absence of
further neuronal differentiation. The molecular mechanisms
underlying this result warrant future study.
Proposed models for the involvement of canonical Wnt
signaling in opV placode development
Since canonical Wnt signaling is not sufficient for opV
placode induction, is it possible that it functions only in
specified cells as a general mechanism for maintaining or
further promoting placodal cell fate? One possible model is that
canonical Wnt signaling acts as a downstream “lock-in” step for
Pax3+ cranial ectoderm cells, stabilizing Pax3 expression and
enabling cells to adopt their specified fate. This is similar to
what may be happening in cranial ectoderm cells in the otic
placode, where it has been shown that initial otic placode
development requires combined Wnt and Fgf signals (Ladher et
al., 2000, 2005). Clarifying these results, Ohyama et al. (2006)
proposed a model wherein Fgf signaling specifies a domain of
Pax2-expressing cells that must subsequently receive Wnt
signaling to adopt an otic placode fate. Wnt signaling in otic
placode development also has an important later function, along
with Sonic Hedgehog, in patterning (reviewed by Brigande et
al., 2000; Fekete and Wu, 2002; Ohyama et al., 2006). This is
also consistent with the model proposed by Arias and Hayward
(2006), in which Wnt signaling stabilizes and maintains gene
expression during cell fate transitions and other developmental
processes, enabling the adoption of specific cell fates. The data
presented here support a model requiring multiple signals, since
we show that canonical Wnt signaling is required for adoption
405R.N.T. Lassiter et al. / Developmental Biology 308 (2007) 392–406and maintenance of the opV placode cell fate, but is not itself
sufficient to induce competent cells toward that same fate.
Alternatively, one cannot rule out Wnts playing a dual role in
opV placode cell specification. In this model, the dorsal neural
tube emits a canonical Wnt signal, in conjunction with other
signal(s), such as FGF or BMP, which act together to induce or
specify competent ectoderm to become Pax3+ opV placode
cells. Subsequently Wnts, either from within the cranial
ectoderm or adjacent tissue, act to maintain Pax3 expression
and the opV placode cell fate until cellular differentiation. This
is supported somewhat by the result that only 12 h after
electroporation of 2–6ss embryos, Pax3 is not present in DN-
Tcf electroporated cells. When considering the timing of normal
Pax3 specification, loss of maintenance would be occurring
nearly at the same time as initial Pax3 expression. Similar multi-
step requirements for Wnt signaling occur in other develop-
mental systems, such as in the developing somites, where
canonical and non-canonical Wnt signals function throughout
the several steps of myogenesis (Marcelle et al., 1997; Schmidt
et al., 2000, 2004; Linker et al., 2003, 2005; Geetha-Loganathan
et al., 2006), and have been shown to regulate Pax3 activity
directly (Brunelli et al., 2007). Regardless of the interpretation
of these results, a requirement for canonical Wnt signaling in
opV placode development helps explain the previous observa-
tion that Wnt-1-deficient mice have a reduced opV nerve (Ikeya
et al., 1997).
Conclusions
The stepwise process of cell fate determination is often a
complex process of cell–cell signaling and continued fate
restriction. While the tissue interactions required for opV
placode development have been known for some time through
classical embryological experiments, the molecules involved in
the process have eluded discovery. We have demonstrated that
canonical Wnt signaling is required for cells to adopt the opV
placode cell fate, and must be maintained for their continued
differentiation. Canonical Wnt signaling, however, is not
sufficient, since activating this signal transduction pathway
alone does not promote cells toward an opV placode fate. The
specification of these cells, therefore, requires additional
signals, which remain elusive. Future studies will aim to
identify the additional molecular cues that must be involved in
opV placode induction and differentiation.
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